Induction of protective antitumor immunity through attenuation of ERAAP function

Journal of Immunology

Volumn 190, Issue 11, 2013, Pages 5839-5846

  James, Edward ^a,b   Bailey, Ian ^a,c   Sugiyarto, Gessa ^a,b   Elliott, Tim ^a,b  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c UNIVERSITY OF WESTMINSTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPEPTIDASE; ANTINEOPLASTIC AGENT; IMMUNOLOGIC AGENT; LEUCINETHIOL; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEIN ERAAP; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER IMMUNOTHERAPY; CANCER PROGNOSIS; CANCER SURVIVAL; CD8+ T LYMPHOCYTE; COLORECTAL CARCINOMA; CONTROLLED STUDY; CROSS PROTECTION; DRUG EFFICACY; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TREATMENT DURATION; TREATMENT RESPONSE; TUMOR GROWTH; TUMOR IMMUNITY; TUMOR REJECTION; TUMOR VOLUME;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, NEOPLASM; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; HUMANS; LEUCYL AMINOPEPTIDASE; MICE; NEOPLASMS;

EID: 84878035647     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300220     Document Type: Article

References (33)

1. Kloetzel, P. M. 2004. Generation of major histocompatibility complex class I antigens: functional interplay between proteasomes and TPPII. Nat. Immunol. 5: 661-669. (Pubitemid 39023294)
2. Shastri, N., S. Schwab, and T. Serwold. 2002. Producing nature's gene-chips: the generation of peptides for display by MHC class I molecules. Annu. Rev. Immunol. 20: 463-493. (Pubitemid 34293432)
3. Cresswell, P., A. L. Ackerman, A. Giodini, D. R. Peaper, and P. A. Wearsch. 2005. Mechanisms of MHC class I-restricted antigen processing and cross-presentation. Immunol. Rev. 207: 145-157. (Pubitemid 41415014)
4. Garbi, N., G. Hämmerling, and S. Tanaka. 2007. Interaction of ERp57 and tapasin in the generation of MHC class I-peptide complexes. Curr. Opin. Immunol. 19: 99-105. (Pubitemid 46073702)
5. Rock, K. L., I. A. York, and A. L. Goldberg. 2004. Post-proteasomal antigen processing for major histocompatibility complex class I presentation. Nat. Immunol. 5: 670-677. (Pubitemid 39023295)
6. Serwold, T., S. Gaw, and N. Shastri. 2001. ER aminopeptidases generate a unique pool of peptides for MHC class I molecules. Nat. Immunol. 2: 644-651. (Pubitemid 32677633)
7. Saric, T., S. C. Chang, A. Hattori, I. A. York, S. Markant, K. L. Rock, M. Tsujimoto, and A. L. Goldberg. 2002. An IFN-gamma-induced aminopeptidase in the ER, ERAP1, trims precursors to MHC class I-presented peptides. Nat. Immunol. 3: 1169-1176. (Pubitemid 35476828)
8. Saveanu, L., O. Carroll, V. Lindo, M. Del Val, D. Lopez, Y. Lepelletier, F. Greer, L. Schomburg, D. Fruci, G. Niedermann, and P. M. van Endert. 2005. Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum. Nat. Immunol. 6: 689-697. (Pubitemid 41716742)
9. York, I. A., S. C. Chang, T. Saric, J. A. Keys, J. M. Favreau, A. L. Goldberg, and K. L. Rock. 2002. The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8-9 residues. Nat. Immunol. 3: 1177-1184. (Pubitemid 35469702)
10. Serwold, T., F. Gonzalez, J. Kim, R. Jacob, and N. Shastri. 2002. ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum. Nature 419: 480-483.
11. Firat, E., L. Saveanu, P. Aichele, P. Staeheli, J. Huai, S. Gaedicke, A. Nil, G. Besin, B. Kanzler, P. van Endert, and G. Niedermann. 2007. The role of endoplasmic reticulum-associated aminopeptidase 1 in immunity to infection and in cross-presentation. J. Immunol. 178: 2241-2248. (Pubitemid 46233422)
12. Hammer, G. E., F. Gonzalez, M. Champsaur, D. Cado, and N. Shastri. 2006. The aminopeptidase ERAAP shapes the peptide repertoire displayed by major histocompatibility complex class I molecules. Nat. Immunol. 7: 103-112. (Pubitemid 41823874)
13. Yan, J., V. V. Parekh, Y. Mendez-Fernandez, D. Olivares- Villagómez, S. Dragovic, T. Hill, D. C. Roopenian, S. Joyce, and L. Van Kaer. 2006. In vivo role of ER-associated peptidase activity in tailoring peptides for presentation by MHC class Ia and class Ib molecules. J. Exp. Med. 203: 647-659.
14. York, I. A., M. A. Brehm, S. Zendzian, C. F. Towne, and K. L. Rock. 2006. Endoplasmic reticulum aminopeptidase 1 (ERAP1) trims MHC class I-presented peptides in vivo and plays an important role in immunodominance. Proc. Natl. Acad. Sci. USA 103: 9202-9207. (Pubitemid 43902556)
15. Fruci, D., S. Ferracuti, M. Z. Limongi, V. Cunsolo, E. Giorda, R. Fraioli, L. Sibilio, O. Carroll, A. Hattori, P. M. van Endert, and P. Giacomini. 2006. Expression of endoplasmic reticulum aminopeptidases in EBV-B cell lines from healthy donors and in leukemia/lymphoma, carcinoma, and melanoma cell lines. J. Immunol. 176: 4869-4879.
16. Fruci, D., P. Giacomini, M. R. Nicotra, M. Forloni, R. Fraioli, L. Saveanu, P. van Endert, and P. G. Natali. 2008. Altered expression of endoplasmic reticulum aminopeptidases ERAP1 and ERAP2 in transformed non-lymphoid human tissues. J. Cell. Physiol. 216: 742-749.
17. Kamphausen, E., C. Kellert, T. Abbas, N. Akkad, S. Tenzer, G. Pawelec, H. Schild, P. van Endert, and B. Seliger. 2010. Distinct molecular mechanisms leading to deficient expression of ER-resident aminopeptidases in melanoma. Cancer Immunol. Immunother. 59: 1273-1284.
18. James, E., A. Yeh, C. King, F. Korangy, I. Bailey, D. S. Boulanger, B. J. Van den Eynde, N. Murray, and T. J. Elliott. 2010. Differential suppression of tumor-specific CD8+ T cells by regulatory T cells. J. Immunol. 185: 5048-5055.
19. Golgher, D., E. Jones, F. Powrie, T. Elliott, and A. Gallimore. 2002. Depletion of CD25+ regulatory cells uncovers immune responses to shared murine tumor rejection antigens. Eur. J. Immunol. 32: 3267-3275. (Pubitemid 35414884)
20. Kanaseki, T., and N. Shastri. 2008. Endoplasmic reticulum aminopeptidase associated with antigen processing regulates quality of processed peptides presented by MHC class I molecules. J. Immunol. 181: 6275-6282.
21. Blanchard, N., T. Kanaseki, H. Escobar, F. Delebecque, N. A. Nagarajan, E. Reyes-Vargas, D. K. Crockett, D. H. Raulet, J. C. Delgado, and N. Shastri. 2010. Endoplasmic reticulum aminopeptidase associated with antigen processing defines the composition and structure of MHC class I peptide repertoire in normal and virus-infected cells. J. Immunol. 184: 3033-3042.
22. Früh, K., K. Ahn, H. Djaballah, P. Sempé, P. M. van Endert, R. Tampé, P. A. Peterson, and Y. Yang. 1995. A viral inhibitor of peptide transporters for antigen presentation. Nature 375: 415-418.
23. Hill, A., P. Jugovic, I. York, G. Russ, J. Bennink, J. Yewdell, H. Ploegh, and D. Johnson. 1995. Herpes simplex virus turns off the TAP to evade host immunity. Nature 375: 411-415.
24. Sanderson, S., and N. Shastri. 1994. LacZ inducible, antigen/MHC-specific T cell hybrids. Int. Immunol. 6: 369-376. (Pubitemid 24087229)
25. Hammer, G. E., F. Gonzalez, E. James, H. Nolla, and N. Shastri. 2007. In the absence of aminopeptidase ERAAP, MHC class I molecules present many unstable and highly immunogenic peptides. Nat. Immunol. 8: 101-108. (Pubitemid 46242364)
26. Nagarajan, N. A., F. Gonzalez, and N. Shastri. 2012. Nonclassical MHC class Ib-restricted cytotoxic T cells monitor antigen processing in the endoplasmic reticulum. Nat. Immunol. 13: 579-586.
27. Read, S., V. Malmström, and F. Powrie. 2000. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J. Exp. Med. 192: 295-302. (Pubitemid 30470312)
28. Curran, M. A., W. Montalvo, H. Yagita, and J. P. Allison. 2010. PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors. Proc. Natl. Acad. Sci. USA 107: 4275-4280.
29. Cifaldi, L., E. Lo Monaco, M. Forloni, E. Giorda, S. Lorenzi, S. Petrini, E. Tremante, D. Pende, F. Locatelli, P. Giacomini, and D. Fruci. 2011. Natural killer cells efficiently reject lymphoma silenced for the endoplasmic reticulum aminopeptidase associated with antigen processing. Cancer Res. 71: 1597-1606.
30. Pagès, F., A. Berger, M. Camus, F. Sanchez-Cabo, A. Costes, R. Molidor, B. Mlecnik, A. Kirilovsky, M. Nilsson, D. Damotte, et al. 2005. Effector memory T cells, early metastasis, and survival in colorectal cancer. N. Engl. J. Med. 353: 2654-2666. (Pubitemid 41817714)
31. Ropponen, K. M., M. J. Eskelinen, P. K. Lipponen, E. Alhava, and V. M. Kosma. 1997. Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer. J. Pathol. 182: 318-324. (Pubitemid 27285785)
32. Salama, P., M. Phillips, F. Grieu, M. Morris, N. Zeps, D. Joseph, C. Platell, and B. Iacopetta. 2009. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. J. Clin. Oncol. 27: 186-192.
33. Koebel, C. M., W. Vermi, J. B. Swann, N. Zerafa, S. J. Rodig, L. J. Old, M. J. Smyth, and R. D. Schreiber. 2007. Adaptive immunity maintains occult cancer in an equilibrium state. Nature 450: 903-907. (Pubitemid 350231320)